The UK's National Health Service needs to form some kind of committee to evaluate the potential of diagnostic tests in order to take full advantage of advances in genomic medicine, says the Times Online's Mark Henderson. Two science think tanks at the University of Cambridge warn that "the potential of genetic testing to deliver better treatments at lower cost will be delayed unless there is a system to establish the benefits," Henderson says.